We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Repurposed Cancer Drug Could Treat Duchenne Muscular Dystrophy

News   Jun 30, 2017 | Original Story from the NIH

 
Repurposed Cancer Drug Could Treat Duchenne Muscular Dystrophy

Diaphragm muscle from SU9516 treated dystrophin deficient mouse showing nuclei (blue), myofibers (outlined in red) and regenerating muscle fibers (green). Credit: Burkin lab at the University of Nevada, Reno School of Medicine

 
 
 

RELATED ARTICLES

Single-cell Analysis Opens Doors for Targeted Treatment in Autism Spectrum Disorder

News

Researchers have adopted single-cell analysis to uncover the molecular underpinnings of Autism Spectrum Disorder (ASD). Their findings may have implications for targeted therapeutics.

READ MORE

Broccoli Compound Restores Potent Cancer Cell Suppressor Function

News

Researchers report that indole-3-carbinol (I3C) – a natural compound found in broccoli – can be used to therapeutically target a gene (WWP1) known to play a role in several human cancers.

READ MORE

Progress in Priming Stem Cell Cardiomyocyte Maturation

News

Speeding up the transformation of induced pluripotent stem cells into cardiomyocytes is of interest for researchers involved in regenerative medicine, and drug development for cardiac diseases.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE